ATE197798T1 - Medrogeston - Google Patents

Medrogeston

Info

Publication number
ATE197798T1
ATE197798T1 AT95302934T AT95302934T ATE197798T1 AT E197798 T1 ATE197798 T1 AT E197798T1 AT 95302934 T AT95302934 T AT 95302934T AT 95302934 T AT95302934 T AT 95302934T AT E197798 T1 ATE197798 T1 AT E197798T1
Authority
AT
Austria
Prior art keywords
alpha
beta
dione
ene
dimethylpregnan
Prior art date
Application number
AT95302934T
Other languages
English (en)
Inventor
Michael William Winkley
Robert Dempster Mitchell
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/239,187 external-priority patent/US5428151A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE197798T1 publication Critical patent/ATE197798T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT95302934T 1994-05-05 1995-04-28 Medrogeston ATE197798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/239,187 US5428151A (en) 1994-05-05 1994-05-05 Medrogestrone production

Publications (1)

Publication Number Publication Date
ATE197798T1 true ATE197798T1 (de) 2000-12-15

Family

ID=22901004

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99200264T ATE269087T1 (de) 1994-05-05 1995-04-28 6 beta-hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 - ene - 3,20 - dion, als hemmer der proliferation von glatten muskelzellen
AT95302934T ATE197798T1 (de) 1994-05-05 1995-04-28 Medrogeston

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99200264T ATE269087T1 (de) 1994-05-05 1995-04-28 6 beta-hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 - ene - 3,20 - dion, als hemmer der proliferation von glatten muskelzellen

Country Status (11)

Country Link
EP (1) EP0955049B1 (de)
JP (1) JP2007119500A (de)
KR (1) KR100365601B1 (de)
AT (2) ATE269087T1 (de)
DE (2) DE69533178T2 (de)
DK (2) DK0680970T3 (de)
ES (2) ES2219995T3 (de)
HU (1) HU226298B1 (de)
PT (2) PT955049E (de)
SI (2) SI0955049T1 (de)
TW (1) TW390886B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7129392B2 (ja) * 2018-10-26 2022-09-01 キヤノン株式会社 組成物、それを有する有機発光素子、表示装置、撮像装置、電子機器及び移動体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170936A (en) * 1963-08-07 1965-02-23 American Home Prod Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione
JPS57106697A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same
JPS57106698A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same

Also Published As

Publication number Publication date
HU226298B1 (en) 2008-08-28
JP2007119500A (ja) 2007-05-17
HU0600432D0 (en) 2006-07-28
DE69519488T2 (de) 2001-06-07
DE69519488D1 (de) 2001-01-04
TW390886B (en) 2000-05-21
EP0955049A3 (de) 2003-01-08
SI0955049T1 (en) 2004-10-31
HK1009970A1 (en) 1999-06-11
PT680970E (pt) 2001-04-30
KR950032266A (ko) 1995-12-20
EP0955049B1 (de) 2004-06-16
DE69533178T2 (de) 2005-07-28
ATE269087T1 (de) 2004-07-15
DK0680970T3 (da) 2000-12-27
ES2219995T3 (es) 2004-12-01
PT955049E (pt) 2004-09-30
DK0955049T3 (da) 2004-10-11
DE69533178D1 (de) 2004-07-22
KR100365601B1 (ko) 2003-12-24
EP0955049A2 (de) 1999-11-10
SI0680970T1 (en) 2001-02-28
ES2151941T3 (es) 2001-01-16

Similar Documents

Publication Publication Date Title
EP0608838A3 (de) Methode zur Herstellung einer ungesättigten Carbonsäure.
ATE172979T1 (de) Verfahren zur herstellung von d-maltose- monoestern mit einem hohen gehalt von 6-0'-ester und ihre verwendung in kosmetika, zahnpflegemitteln, pharmazeutik und lebensmitteln
EP0444640A3 (en) Process for biological production of organic acids
EP0460917A3 (en) Method of producing eicosapentaenoic acid or an ester derivative thereof
IT7925433A0 (it) Procedimento di produzione di acidi carbossilici e loro esteri.
BE840078A (fr) Procede de carboxylation de substrat organiques avec de l'anhydride carbonique
ES2151941T3 (es) Medrogestona.
ATE140925T1 (de) Neues verfahren zur herstellung von 6alpha, 9alphadifluoro-sterioden und zwischenprodukte davon
DE69008070D1 (de) Verfahren zur Herstellung eines alpha-Ketocarbonsäureester.
DE69327789D1 (de) Verfahren zur umwandung von taxanen in baccatin iii und 10-desacetylbaccatin iii
ES2053568T3 (es) Un procedimiento para producir esteres de acidos carboxilicos.
HU9202230D0 (en) Method for producing beta-lactames
FI932542A0 (fi) Foerfarande foer framstaellning av estrar av 2,2-dimetyl-3-((Z)-1-propenyl)cyklopropankarboxylsyra samt mellanprodukter
ATE86597T1 (de) Verfahren zur stereoselektiven herstellung von z- 1,2-diaryl-allyl-chloriden und deren umsetzung zu azolylmethyloxiranen sowie neue zwischenprodukte.
DE69116879D1 (de) Verfahren und reinigung von essigsäureanhydrid und essigsäure
FR2686897B1 (fr) Procede en continu de fabrication d'acides organiques.
ATE128471T1 (de) Neues verfahren zur herstellung delta-9(11)- steroide.
ATE24322T1 (de) Verfahren und zwischenprodukte zur herstellung des 1,1-dioxopenicillanoylmethylesters der 6-beta-aminopenicillansaeure.
DE69110374D1 (de) Verfahren zur erhöhung des alpha/beta-verhältnisses in einer aspartamkupplungsreaktion.
DE69005317D1 (de) Verfahren und Zwischenprodukte zur Herstellung von Isopropylestern von 3S-amino-2R-hydroxyalkansäuren.
JPS57193449A (en) Novel tin 2-nitrothiophenol complex compound, its preparation and preparation of threo substituted- propionic acid derivative with the same
KR920004350A (ko) 5-알킬피리딘-2,3-디카르복실산에서 에스테르의 제조방법
BR9104254A (pt) Processo para producao de anidrido de acido carboxilico
ATE182T1 (de) Verfahren zur herstellung von 3-substituierten 1-cyclo-propancarbonsaeuren und erhaltene produkte.
GEP19970840B (en) A process for the preparation of propionic acid derivatives and stereochemical isomers thereof

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee